Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    1697056 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
Conditions: Tumor;   Cancer Pain;   Breakthrough Cancer Pain;   Neuropathic Pain
Interventions: Drug: Morphine;   Drug: Fentanyl;   Drug: Methadone;   Drug: Buprenorphine;   Drug: Oxycodone;   Drug: Hydromorphone;   Drug: Tapentadol
To Top

† Indicates status has not been verified in more than two years